Conjugation with Dihydrolipoic Acid Imparts Caffeic Acid Ester Potent Inhibitory Effect on Dopa Oxidase Activity of Human Tyrosinase
暂无分享,去创建一个
[1] V. Namasivayam,et al. Inhibitors of Melanogenesis: An Updated Review. , 2018, Journal of medicinal chemistry.
[2] K. Röhm,et al. Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase , 2018, International journal of molecular sciences.
[3] F. Solano. On the Metal Cofactor in the Tyrosinase Family , 2018, International journal of molecular sciences.
[4] D. Ruiz-Molina,et al. Bioinspired Catechol-Based Systems: Chemistry and Applications , 2017, Biomimetics.
[5] E. Flori,et al. The α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines , 2017, Journal of experimental & clinical cancer research : CR.
[6] J. García-Borrón,et al. MC1R signaling. Intracellular partners and pathophysiological implications. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[7] A. Napolitano,et al. 2-S-Lipoylcaffeic Acid, a Natural Product-Based Entry to Tyrosinase Inhibition via Catechol Manipulation , 2017, Biomimetics.
[8] K. Wakamatsu,et al. Tyrosinase-Catalyzed Oxidation of the Leukoderma-Inducing Agent Raspberry Ketone Produces (E)-4-(3-Oxo-1-butenyl)-1,2-benzoquinone: Implications for Melanocyte Toxicity. , 2017, Chemical research in toxicology.
[9] V. Namasivayam,et al. Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors , 2017, Journal of enzyme inhibition and medicinal chemistry.
[10] M. Sugumaran,et al. Critical Analysis of the Melanogenic Pathway in Insects and Higher Animals , 2016, International journal of molecular sciences.
[11] M. Sugumaran. Reactivities of Quinone Methides versus o-Quinones in Catecholamine Metabolism and Eumelanin Biosynthesis , 2016, International journal of molecular sciences.
[12] H. Marona,et al. Melanogenesis Inhibitors: Strategies for Searching for and Evaluation of Active Compounds. , 2016, Current medicinal chemistry.
[13] S. Shin,et al. Different effects of five depigmentary compounds, rhododendrol, raspberry ketone, monobenzone, rucinol and AP736 on melanogenesis and viability of human epidermal melanocytes , 2016, Experimental dermatology.
[14] K. Wakamatsu,et al. Effects of rhododendrol and its metabolic products on melanocytic cell growth. , 2015, Journal of dermatological science.
[15] K. Wakamatsu,et al. A convenient screening method to differentiate phenolic skin whitening tyrosinase inhibitors from leukoderma-inducing phenols. , 2015, Journal of dermatological science.
[16] K. Wakamatsu,et al. Tyrosinase‐catalyzed oxidation of rhododendrol produces 2‐methylchromane‐6,7‐dione, the putative ultimate toxic metabolite: implications for melanocyte toxicity , 2014, Pigment cell & melanoma research.
[17] Z. Abdel‐Malek,et al. MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation , 2014, Pigment cell & melanoma research.
[18] Tamio Suzuki,et al. Rhododendrol, a depigmentation‐inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase‐dependent mechanism , 2014, Pigment cell & melanoma research.
[19] V. Hearing,et al. Melanocytes and their diseases. , 2014, Cold Spring Harbor perspectives in medicine.
[20] J. García-Borrón,et al. Differential and competitive regulation of human melanocortin 1 receptor signaling by &bgr;-arrestin isoforms , 2013, Journal of Cell Science.
[21] M. Picardo,et al. Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo. , 2012, Annales de dermatologie et de venereologie.
[22] J. Munoz-Munoz,et al. Unravelling the suicide inactivation of tyrosinase: A discrimination between mechanisms , 2012 .
[23] Hye-Ryung Choi,et al. Topical Hypopigmenting Agents for Pigmentary Disorders and Their Mechanisms of Action , 2012, Annals of dermatology.
[24] A. Slominski,et al. L‐tyrosine and L‐dihydroxyphenylalanine as hormone‐like regulators of melanocyte functions , 2012, Pigment cell & melanoma research.
[25] Yoon-Sik Lee,et al. Dual effects of caffeoyl-amino acidyl-hydroxamic acid as an antioxidant and depigmenting agent. , 2011, Bioorganic & medicinal chemistry letters.
[26] Z. Abdel‐Malek,et al. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. , 2011, Molecular endocrinology.
[27] V. Hearing,et al. Update on the regulation of mammalian melanocyte function and skin pigmentation. , 2011, Expert review of dermatology.
[28] C. Bertolotto,et al. Fifteen‐year quest for microphthalmia‐associated transcription factor target genes , 2010, Pigment cell & melanoma research.
[29] N. Smit,et al. The Hunt for Natural Skin Whitening Agents , 2009, International journal of molecular sciences.
[30] A. B. Pérez-Oliva,et al. Mahogunin Ring Finger-1 (MGRN1) E3 Ubiquitin Ligase Inhibits Signaling from Melanocortin Receptor by Competition with Gαs* , 2009, The Journal of Biological Chemistry.
[31] R. Randall Wickett,et al. Mechanisms Regulating Skin Pigmentation: The Rise and Fall of Complexion Coloration , 2009, International journal of molecular sciences.
[32] Te-Sheng Chang,et al. An Updated Review of Tyrosinase Inhibitors , 2009, International journal of molecular sciences.
[33] K. Wakamatsu,et al. Chemistry of Mixed Melanogenesis—Pivotal Roles of Dopaquinone † , 2008, Photochemistry and photobiology.
[34] V. Hearing,et al. The Protective Role of Melanin Against UV Damage in Human Skin † , 2008, Photochemistry and photobiology.
[35] C. Boeriu,et al. Novel peptides with tyrosinase inhibitory activity , 2007, Peptides.
[36] Francisco Solano,et al. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. , 2006, Pigment cell research.
[37] T. Okada,et al. Evidence for covalent lipoyl adduction with dopaquinone following tyrosinase-catalyzed oxidation. , 2006, Biochemical and biophysical research communications.
[38] D. Tobin,et al. Melanin pigmentation in mammalian skin and its hormonal regulation. , 2004, Physiological reviews.
[39] F. Solano,et al. Conformation-dependent Post-translational Glycosylation of Tyrosinase , 2003, The Journal of Biological Chemistry.
[40] E. Price,et al. Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation. , 2002, The Journal of investigative dermatology.
[41] Mei Hong,et al. Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. , 2002, Pigment cell research.
[42] F. Solano,et al. Identification of active site residues involved in metal cofactor binding and stereospecific substrate recognition in Mammalian tyrosinase. Implications to the catalytic cycle. , 2002, Biochemistry.
[43] K. Imai,et al. Synthetic Search for Cosmetic Ingredients: Preparations, Tyrosinase Inhibitory and Antioxidant Activities of Caffeic Amides , 2002 .
[44] A. Bilska,et al. [Biologic properties of lipoic acid]. , 2002, Postepy higieny i medycyny doswiadczalnej.
[45] P. Riley. Tyrosinase kinetics: a semi-quantitative model of the mechanism of oxidation of monohydric and dihydric phenolic substrates. , 2000, Journal of theoretical biology.
[46] Andreina Santagostino,et al. A User-Friendly Entry to 2-Iodoxybenzoic Acid (IBX) , 1999 .
[47] C. A. Ramsden,et al. Melanogenesis-targeted anti-melanoma pro-drug development: effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system. , 1997, European journal of cancer.
[48] C. A. Ramsden,et al. Tyrosinase-mediated cytotoxicity of 4-substituted phenols: prediction of thiol reactivity of the derived o-quinones , 1995 .
[49] L. Packer,et al. alpha-Lipoic acid as a biological antioxidant. , 1995, Free radical biology & medicine.
[50] C. A. Ramsden,et al. Tyrosinase‐mediated cytotoxicity of 4‐substituted phenols: Quantitative structure‐thiol-reactivity relationships of the derived o‐quinones , 1994, Anti-cancer drug design.
[51] K. Urabe,et al. A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). , 1994, The Journal of biological chemistry.
[52] A. Winder,et al. New assays for the tyrosine hydroxylase and dopa oxidase activities of tyrosinase. , 1991, European journal of biochemistry.
[53] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[54] V. Hearing,et al. Mammalin tyrosinase. Stoichiometry and measurement of reaction products. , 1980, Biochimica et biophysica acta.
[55] I. C. Gunsalus,et al. Biosynthesis and Structure of Lipoic Acid Derivatives1 , 1956 .